A Phase 3 Single Center Study of Islet Transplantation in Non-uremic Diabetic Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
Type 1 diabetes is an autoimmune disease in which the insulin-producing pancreatic beta cells are destroyed, resulting in poor blood sugar control. The purpose of this study is to determine the safety and effectiveness of islet transplantation, combined with immunosuppressive medications, specifically using Campath as induction, for treating type 1 diabetes in individuals experiencing hypoglycemia unawareness and severe hypoglycemic episodes.
Epistemonikos ID: 8c4143e61ea545c436f12e1f3776341488b2ed4a
First added on: May 11, 2024